Bod Australia Observational Study of Medicinal Cannabis Therapy
CA Clinics is happy to announce they are participating in the BodOLOS study with Bod Australia, a recognised leader in the Australian medicinal cannabis sector. This observational study is focused on monitoring patients treatment journey whilst being prescribed one of Bod’s cannabidiol products for treatment of their medical condition.
The results of this study will help inform future research and development efforts including future clinical trials, as well as prescribing guidance for medicinal cannabis medicines.
As a study participant you will be asked to complete online surveys throughout your treatment whilst you continue to visit your prescribing doctor that will manage your care. The first two bottles of study medication will be provided free* and reduced pricing will then be available for the remainder of the study duration.
*Patients will still be required to pay pharmacy dispensing fees and any applicable postage costs. Normal clinical consultation fees apply.
Patients 18 and older, that have not been prescribed cannabis before and are approved for prescription of a Bod Medicabilis products through CA Clinics doctors will be eligible to enrol in the study.
Medicinal Cannabis Therapy
Am I eligible?
Patients 18 and older that are approved for prescription of a Bod Medicabilis products through CA Clinics doctors will be eligible to enrol in the study.
For more information please see the detailed Participant Information and Consent Form.
If you are interested in finding out more please contact CA Clinics at 1300 991 477.